Whilst GLP-1 medications have well-established benefits for metabolic health, patients and clinicians have begun questioning whether these drugs might influence other conditions, including dermatological concerns such as acne vulgaris
Ozempic rebates reduced by health insurer HBF after claims double in wake of drug's release Thu 9 May 2024 at 11:17am , updated Thu 9 May 2024 at 2:44pm Western Australia's largest private health insurer will slash rebates for weight loss drugs including Ozempic, saying the rise in claims has become unsustainable
Our team of experienced professionals is dedicated to providing exceptional service and support, ensuring that our clients receive timely and efficient solutions tailored to their needs
Why selectivity matters Think of receptor biology as a lock-and-key system
Heres where the evidence stands today, and what experts say you should think about before taking these types of medications
DSIP is a neuropeptide that promotes deep, restorative delta-wave sleep